Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

First Page		Document Content
Date: 2010-01-13 06:39:09 Medicine Clinical medicine Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Breast cancer Treatment of cancer Chemotherapy Metastatic breast cancer Graft versus tumor effect Cell therapy Lumpectomy		Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer Add to Reading List Source URL: www.nature.com Download Document from Source Website File Size: 153,42 KB Share Document on Facebook

	Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo , DocID: 1uQqF - View Document
	Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at DocID: 1trwM - View Document
	· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract DocID: 1rmV3 - View Document
	Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer DocID: 1riiF - View Document
	Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti DocID: 1rf3r - View Document